DePuy Discontinues Pinnacle Hip Implants as Lawsuits Mount
As Johnson & Johnson struggles to settle thousands of lawsuits concerning its DePuy ASR hip implants, it is still unclear how the company plans to approach the injuries caused by its previous Pinnacle Hip Replacement System, another metal-on-metal hip replacement.
About the Pinnacle Hip Replacement System
The Pinnacle Hip Replacement System was DePuy’s predecessor its ASR XL Acetabular System and ASR Hip Resurfacing System, both of which are the subject of multi-district litgation and individual lawsuits facing the company.
Originally created as an attempt to enhance durability and eliminate the issue of device failure due to over use, doctors now estimate more than 10 percent of the Pinnacle devices will fail within the next two to three years.
Further, previous reports of Pinnacle hip implant failures have found evidence of severe necrosis (tissue death) and ruptured tendons.
This is due to a device defect that is shared by all metal-on-metal implants – as the metal joint and socket begin to rub, the implant begin to expel small metal shavings that can damage the tissue around the implant area and can even enter the blood stream, causing metallosis.
Unfortunately, though the company is aware of this problem, DePuy has yet to issue a recall for the Pinnacle Hip Replacement System and have only discontinued manufacturing the device.
DePuy ASR Lawsuits
- According to DrugWatch, DePuy is currently facing more than 8,300 lawsuits alleging injury due to its ASR hip implants.
- Parent company Johnson & Johnson is currently awaiting court approval for a $2.5 billion proposed settlement that would settle 7,500 of the ASR cases.
- While more than 4,000 claims have been filed in connection to the Pinnacle hip system, Johnson & Johnson has announced that patients involved in these lawsuits are not eligible for the current settlement.
- Trials for the Pinnacle implants are set to begin September of 2014.
Contact an Experienced Pinnacle Hip Implant Attorney
Thomas J. Henry are leaders in the area of drug and product liability litigation. Our Defective Drug and Products Division have extensive knowledge and resources in order to represent our clients efficiently and aggressively. The Defective Drug and Products Division represent a multitude of people who are battling against manufacturers of medical devices and/ or defective pharmaceuticals.
If you or a loved one have been injured by or have developed serious side-effects from the use of defective medications or medical devices, contact Thomas J. Henry immediately. We represent clients/victims all over the country. We are available 24/7, nights and weekends.